LEXG-Lexicon Genetics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LEXG-Lexicon Genetics

LXRX 1.360

-1.4%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who started this subject	5/3/2004 9:10:47 PM
From: mopgcw	Read Replies (1) of 254

Lexicon Genetics (LEXG-NNM) by W.R. Hambrecht (6.82, April 22) We are initiating coverage with a Buy rating and a 12-month price target of 10....Over the next 12 months, we expect new collaborations to be the primary value driver for the stock, while over the next 12 months to 24 months, we expect a significant number of novel pharmaceutical product candidates to enter clinical development. Over that time, we also expect Lexicon to cull through approximately 900 genes per year, yielding approximately 24 new discovery programs per year.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next